Recent safety concerns surrounding the use of gadolinium-based contrast agents (GBCAs)
have spurred research into identifying alternatives to GBCAs for use with magnetic …

In this contribution, two couples of cationic enantiomeric complexes [(R, R)-[LnL] Cl and (S,
S)-[LnL] Cl, with Ln= Sm and Eu and L= N, N′-bis (2-pyridylmethyl)-1, 2-(R, R or S, S) …

We present a quantitative analysis of the thermodynamic stabilities of Mn (II) complexes,
defined by the equilibrium constants (log K MnL values) and the values of pMn obtained as …

We present a set of donor radii for the rare-earth cations obtained from the analysis of
structural data available in the Cambridge Structural Database (CSD). Theoretical …

Synthetic methodologies were developed to achieve the preparation of ligands L1 and L2
consisting of tacn-and pyclen-based chelators decorated with pyridinylphosphonic pendant …

A novel Fe (III) complex, Fe-t BPCDTA, was synthesized and explored as a potential contrast
agent for MRI. Compared to established agents like Fe-EDTA and Fe-t CDTA, Fe-t BPCDTA …

The discovery of the nephrogenic systemic fibrosis (NSF) and its link with the in vivo
dissociation of certain Gd (III)-based contrast agents (CAs) applied in the magnetic …

In recent years, pyclen-based complexes have attracted a great deal of interest as magnetic
resonance imaging (MRI) contrast agents (CAs) and luminescent materials, as well as …

Diethylenetriaminepentaacetic acid (DTPA) is a chelating agent whose complex with the
Gd3+ ion is used in medical imaging. DTPA is also used in lanthanide‐actinide separation …

Objectives Gadopiclenol is aq= 2 pyclen gadolinium-based contrast agent (GBCA) recently
approved by the Food and Drug Administration, European Medicines Agency, and other …